Immutep Limited - Asset Resilience Ratio

Latest as of December 2024: 46.82%

Immutep Limited (YP1A) has an Asset Resilience Ratio of 46.82% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read YP1A total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

€85.37 Million

≈ $99.81 Million USD Cash + Short-term Investments

Total Assets

€182.33 Million

≈ $213.16 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2023–2024)

This chart shows how Immutep Limited's Asset Resilience Ratio has changed over time. See YP1A net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Immutep Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Immutep Limited (YP1A) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€85.37 Million	46.82%
Total Liquid Assets	€85.37 Million	46.82%

Asset Resilience Insights

Very High Liquidity: Immutep Limited maintains exceptional liquid asset reserves at 46.82% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Immutep Limited Industry Peers by Asset Resilience Ratio

Compare Immutep Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Royalty Pharma Plc NASDAQ:RPRX	Biotechnology	0.10%
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	3.28%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	4.52%
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	35.56%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.35%

Annual Asset Resilience Ratio for Immutep Limited (2023–2024)

The table below shows the annual Asset Resilience Ratio data for Immutep Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-06-30	9.96%	€20.09 Million ≈ $23.48 Million	€201.58 Million ≈ $235.67 Million	--
2023-06-30	0.00%	€0.00 ≈ $0.00	€147.45 Million ≈ $172.38 Million	--

pp = percentage points

About Immutep Limited

F:YP1A Germany Biotechnology

Market Cap

$61.95 Million

€52.99 Million EUR

Market Cap Rank

#21038 Global

#1892 in Germany

Share Price

€0.36

Change (1 day)

-16.28%

52-Week Range

€0.24 - €2.64

All Time High

€4.52